A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)

Clinical trial NCT04093349 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04093349
Sponsor: Spark Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pompe Disease Pompe Disease (Late-onset)Glycogen Storage Disease Type 2 Glycogen Storage Disease Type II LOPD Lysosomal Storage Diseases Acid Maltase Deficiency

Start date: 2020-10-01
Primary completion: 2032-04-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.